Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety of the dapivirine vaginal ring when inserts once every 4
weeks in postmenopausal women over 12 weeks of product use.
Phase:
Phase 2
Details
Lead Sponsor:
International Partnership for Microbicides, Inc.
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)